Real-world outcomes of osimertinib (Osi) vs. afatinib or erlotinib in patients with classical vs. atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC). This is an ASCO Meeting Abstract ...
One of the most promising uses of artificial intelligence (AI) machine learning is digital diagnostics for the medical and health care fields. A new study published in the science journal Cell Reports ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback